Xvivo Perfusion AB (publ) (0RKL.L) LSE

180.60

-5.93377(-3.18%)

Updated at August 18 05:35PM

Currency In SEK

Valuation

Market Cap15.4B
Enterprise Value15.02B
P/E Ratio51.42
PEG Ratio-2.76
Price/Sales Ratio6.96
Price/Book Ratio2.74
Enterprise/Revenue6.7
Enterprise/EBITDA64.13

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.08

Management Effectiveness

Return On Assets0.05
Return On Equity0.05

Income Statement

Revenue822.42M
Revenue/Share26.13
Gross Profit616.42M
EBITDA272.97M
Net Income172.18M
Diluted EPS5.44

Balance Sheet

Total Cash323M
Total Cash/Share10.25
Total Debt110.81M
Total Debt/Equity0.05
Current Ratio4.81
Book Value Per Share66.41

Price History

52-Week Change-66.37
52-Week High343.52
52-Week Low179.8
Moving Average 50 Days291.55
Moving Average 200 Days282.98

Statistics

Average Volume9,843
Shares Outstanding31.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A